Meadow Creek Investment Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $32K | Hold |
4,352
| – | – | ﹤0.01% | 1289 |
|
|
2019
Q2 | $40K | Hold |
4,352
| – | – | ﹤0.01% | 1296 |
|
|
2019
Q1 | $23K | Sell |
4,352
-850
| -16% | -$4.49K | ﹤0.01% | 1306 |
|
|
2018
Q4 | $23K | Buy |
+5,202
| New | +$23K | ﹤0.01% | 1256 |
|
|
2018
Q3 | – | Sell |
-57,868
| Closed | -$406K | – | 1336 |
|
|
2018
Q2 | $406K | Buy |
57,868
+2,890
| +5% | +$20.3K | 0.01% | 734 |
|
|
2018
Q1 | $782K | Hold |
54,978
| – | – | 0.02% | 495 |
|
|
2017
Q4 | $482K | Sell |
54,978
-6,086
| -10% | -$53.4K | 0.01% | 670 |
|
|
2017
Q3 | $714K | Buy |
61,064
+3,842
| +7% | +$44.9K | 0.02% | 500 |
|
|
2017
Q2 | $799K | Buy |
57,222
+22,712
| +66% | +$317K | 0.02% | 466 |
|
|
2017
Q1 | $474K | Hold |
34,510
| – | – | 0.01% | 557 |
|
|
2016
Q4 | $247K | Buy |
+34,510
| New | +$247K | 0.01% | 669 |
|